Advertisement

Topics

DermTech, Inc. Company Profile

00:08 EST 19th November 2017 | BioPortfolio

Headquartered in La Jolla, California, DermTech International (www.dermtech.com) is developing its proprietary EGIR(TM) (Epidermal Genetic Information Retrieval) technology for genomic-based, non-invasive disease detection, improved pharmaceutical R&D and personalized medicine to help direct appropriate treatment. The company's first product candidate in development is a non-invasive test to detect the presence of melanoma. The EGIR technology uses custom adhesive tape to easily obtain RNA from the upper layer of skin overlying a suspicious lesion. A proprietary 19-gene biomarker is then used to analyze the genetic material to differentiate potentially life-threatening melanoma from other forms of pigmented lesions. Studies to date show the test to be 100% sensitive and 88% specific. Research is also underway to use the EGIR technology to develop highly accurate, non-invasive tests for other cancers and diseases. For additional information, visit www.dermtech.com


News Articles [10 Associated News Articles listed on BioPortfolio]

DermTech brings in $10mm of expected $15mm Series C round

DermTech Inc. (detection and treatment of skin cancers and inflammatory dermatological diseases) raised $10mm of an expected $15mm Series C round from RTW Investments and returning private investors. ...

DermTech Reaches Financing Milestone

DermTech, Inc., the global leader in non-invasive molecular dermatology, announced today that it has raised $10 million of its Series C Preferred equity offering. “We are very p...

DermTech Announces Addition to Board of Directors

LA JOLLA, Calif., Aug. 23, 2017 /PRNewswire/ -- DermTech, Inc., the global leader in non-invasive molecular dermatology, is pleased to announce the appointment of Herman "Herm" Rosenman to its Bo...

DermTech to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

DermTech, Inc., the global leader in non-invasive molecular dermatology, announced today that it will be presenting a business update at the Canaccord Genuity Medical Technologies...

DermTech Appoints Gerald Krueger, MD, to Scientific Advisory Board

LA JOLLA, Calif., Sept. 12, 2017 /PRNewswire/ -- DermTech, Inc., the global leader in non-invasive molecular dermatology, is pleased to announce the appointment of Gerald G Krueger, MD, to its Sc...

DermTech Announces Addition of Harold Rabinovitz to Scientific Advisory Board

DermTech, Inc., the global leader in non-invasive molecular dermatology, announced today the appointment of Harold Rabinovitz, M.D., to its Scientific Advisory Board. Dr. Rabinovi...

DermTech Appoints To Scientific Advisory Board

  Life Sciences Jobs   ...

DermTech Announces Addition of Daniel M. Siegel, MD to Advisory Board

DermTech, Inc., the global leader in non-invasive molecular dermatology, announced today the appointment of Daniel M. Siegel, MD, to its Scientific Advisory Board. Dr. Siegel is a...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

DermTech International, Inc.

Headquartered in La Jolla, California, DermTech is focused on the development of the company's patented Epidermal Genetic Information Retrieval (EGIR(TM)) technology. The EGIR technology uses a custo...

DermTech, Inc.

Headquartered in La Jolla, California, DermTech International (www.dermtech.com) is developing its proprietary EGIR(TM) (Epidermal Genetic Information Retrieval) technology for genomic-based, non-inva...

DermTech International

Founded in 1996, DermTech International has grown to become a leader in the development of molecular techniques for commercial and clinical dermatology applications. Headquartered in San Diego, Calif...

More Information about "DermTech, Inc." on BioPortfolio

We have published hundreds of DermTech, Inc. news stories on BioPortfolio along with dozens of DermTech, Inc. Clinical Trials and PubMed Articles about DermTech, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DermTech, Inc. Companies in our database. You can also find out about relevant DermTech, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Wound management
Anything that breaks the skin is a wound because when the skin is broken, there's a risk of germs getting into the body and causing an infection. Follow and track Wound Care News on BioPortfolio: Wound Car...


Corporate Database Quicklinks



Searches Linking to this Company Record